Alvotech ALVO
NASDAQ ALVO
$4.43 +0.16 (+3.75%)
At close: Aug 21, 2026 · 4:00 PM EDT

Alvotech (ALVO) Other Non-Current Liabilities (2020 - 2026)

Alvotech's (ALVO) quarterly Other Non-Current Liabilities came in at $21.8 million in Q1 2026, down 89.65% YoY from $210.2 million in Q1 2025, and down 59.69% on a QoQ basis from $54.0 million in Q4 2025.

Alvotech (ALVO) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has 7 years of Other Non-Current Liabilities data on file, last reported at $21.8 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 89.65% year-over-year to $21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.8 million (down 89.65% YoY) and the FY2025 annual result came in at $54.0 million, down 74.32% from the prior year.
  • Other Non-Current Liabilities fell to $21.8 million in Q1 2026, from $54.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $520.6 million in Q1 2023 to a low of $21.8 million in Q1 2026.
  • A 5-year average of $238.0 million and a median of $210.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 3285977.26% — and 2026, when it slumped 89.65%.
  • Tracing ALVO's Other Non-Current Liabilities over 5 years: stood at $380.2 million in 2022, then jumped by 36.9% to $520.6 million in 2023, then plunged by 59.62% to $210.2 million in 2024, then plunged by 74.32% to $54.0 million in 2025, then plunged by 59.69% to $21.8 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $21.8 million (Q1 2026), $54.0 million (Q4 2025), and $210.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Alvotech 1.30 Bn 1.30 Bn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.76 Mn
Dec 31, 2025 53.99 Mn
Sep 30, 2025 210.22 Mn
Jun 30, 2025 63.00 Mn
Mar 31, 2025 210.22 Mn
Dec 31, 2024 210.22 Mn
Sep 30, 2024 182.36 Mn
Jun 30, 2024 201.67 Mn
Mar 31, 2024 330.98 Mn
Dec 31, 2023 520.55 Mn
Jun 30, 2023 229.05 Mn
Mar 31, 2023 520.58 Mn
Dec 31, 2022 380.23 Mn
Jun 30, 2022 197.47 Mn
Dec 31, 2021 11,571.00
Dec 31, 2020 534.69 Mn